FormWeb • aspirin

IHS FormWeb

Approved Formulary

Staff Telephone Numbers

Webpage Links

Add Formweb to your mobile device

Android iOS

Search results for:

aspirin

aspirin

Brand names: Aspirin Child Chewable, Ecotrin

Form	Strength
DELAYED RELEASE TABLET, ORAL	325 mg
SUPPOSITORY, RECTAL	300 mg
TABLET, CHEWABLE, ORAL	81 mg
TABLET, ORAL	325 mg

Display Salicylates Class: 28080424

Medication comments:

Refrigerator item (suppository)

Per policy, orders for these non-formulary agents will be changed to formulary equivalents.
Non-Formulary Agent	Formulary Equivalent
aspirin buffered (Ascriptin) 325 mg	aspirin EC (Ecotrin) 325 mg
aspirin EC 81 mg	aspirin chewable 81 mg

Anticoagulant / Antiplatelet Stoppage For Procedures
generic (Brand)	Dept.	Procedure Type (hover over entry for examples)	Stop Medication Prior To Procedure Restart after:
aspirin 325 mg	Anesthesia	High-risk	Primary prophylaxis: 6 days; Secondary prophylaxis: Shared assessment and risk stratification Restart after 24 hours
		Intermediate-risk	Requires shared assessment and risk stratification Restart after 24 hours
		Low-risk	No hold Restart after 24 hours
		Patients with high risk of bleeding (eg, old age, history of bleeding tendency, concurrent uses of other anticoagulants/antiplatelets, liver cirrhosis or advanced liver disease, and advanced renal disease) undergoing low- or intermediate-risk procedures should be treated as intermediate or high risk, respectively.

	Radiology	Invasive Procedures	7 days
	Radiology	Paracentesis/Thoracentesis	No hold
	Surgery	High-risk	7 days Restart after 24 hours
	Surgery	Low-risk	No Hold Restart after 24 hours
aspirin 81 mg	Anesthesia	High-risk	Primary prophylaxis: 6 days; Secondary prophylaxis: Shared assessment and risk stratification Restart after 24 hours
		Intermediate-risk	Requires shared assessment and risk stratification Restart after 24 hours
		Low-risk	No hold Restart after 24 hours
		Patients with high risk of bleeding (eg, old age, history of bleeding tendency, concurrent uses of other anticoagulants/antiplatelets, liver cirrhosis or advanced liver disease, and advanced renal disease) undergoing low- or intermediate-risk procedures should be treated as intermediate or high risk, respectively.

	Radiology	Invasive Procedures	3 days
	Radiology	Paracentesis/Thoracentesis	No hold
	Surgery	High-risk	7 days Restart after 24 hours
	Surgery	Low-risk	No Hold Restart after 24 hours

Last updated: Nov. 22, 2020

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556

This site is intended for the staff of Iredell Memorial Hospital.
While others may view accessible pages, Iredell Memorial Hospital makes no warranty, express or implied,
as to the use of this information outside of Iredell Memorial Hospital.
The content of this policy and procedure document serves as guidance to the delivery of quality patient care.
Care providers are expected to exercise critical thinking and situational awareness skills,
and in specific situations to take such action as is necessary for the delivery of quality patient care.